German pharmaceutical and chemical company Bayer AG this week announced plans to acquire US biotech firm Monsanto.
The company said in a statement that it would buy Monsanto for a price of $128 per share, representing a 44% premium on company’s prior share price. All up, the deal would cost Bayer a massive $66bn, making it one of the largest ever deals in the sector. Talks to finalize this deal had been…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
